Nektar Therapeutics | TalkMarkets

Latest Posts

About This Stock More About This Stock

Sweet Nektar?

Article By: Tim Knight

Monday, April 22, 2024 1:40 PM EDT

NKTR has had a terrible time of it for years, but maybe it’s finally ready to turn around.

In this article: NKTR

Read

Biotech's Lawsuit With Eli Lilly Might Catalyze Stock

Article By: The Life Sciences Report

Friday, March 29, 2024 10:12 PM EDT

Nektar Therapeutics commenced a Phase 2b clinical trial evaluating its lead product candidate rezpegaldesleukin, in patients with severe to very severe alopecia areata, a disease-causing patchy hair loss.

In this article: NKTR

Read

Nektar Upgraded To Neutral From Sell At Goldman Sachs

Article By: The Fly

Monday, March 30, 2020 7:16 AM EDT

Goldman Sachs analyst Paul Choi upgraded Nektar Therapeutics to Neutral from Sell with a price target of $20, up from $18.

In this article: NKTR

Read

Stock Charts To Watch - Monday, Jan. 13

Video By: Harry Boxer

Monday, January 13, 2020 9:06 PM EDT

Ballard Power Systems Inc. had a spike up on big volume on Monday, gaining 74 cents, or 8.16%, to 9.81, after reaching a high of 10.93, on 12 million shares.

In this video: DDD, CGC, BLDP, INMD, LK, LSCC, NKTR, NUAN

Watch